131 related articles for article (PubMed ID: 34240653)
21. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
Zembowicz A; Yang SE; Kafanas A; Lyle SR
Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
[TBL] [Abstract][Full Text] [Related]
22. Performance Testing of RREB1, MYB, and CCND1 Fluorescence In Situ Hybridization in Spindle-Cell and Desmoplastic Melanoma Argues for a Two-Step Test Algorithm.
Weissinger SE; Frick M; Möller P; Horst BA; Lennerz JK
Int J Surg Pathol; 2017 Apr; 25(2):148-157. PubMed ID: 27899693
[TBL] [Abstract][Full Text] [Related]
23. Conjunctival melanoma: pitfalls and dilemmas in management.
Shildkrot Y; Wilson MW
Curr Opin Ophthalmol; 2010 Sep; 21(5):380-6. PubMed ID: 20531189
[TBL] [Abstract][Full Text] [Related]
24. Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance.
Chaparro Tapias TA; Díaz Díaz AL; Secondi R; Coy Villamil H; Sánchez España JC
Arch Soc Esp Oftalmol (Engl Ed); 2018 Nov; 93(11):558-561. PubMed ID: 30072188
[TBL] [Abstract][Full Text] [Related]
25. Four-color fluorescence in-situ hybridization is useful to assist to distinguish early stage acral and cutaneous melanomas from dysplastic junctional or compound nevus.
Lai Y; Wu Y; Liu R; Lu A; Zhou L; Jia L; Diao X; Li Z
Diagn Pathol; 2020 May; 15(1):51. PubMed ID: 32393283
[TBL] [Abstract][Full Text] [Related]
26. Gain of CCND1 May Occur Too Infrequently in Cutaneous Melanoma, and Too Late in Melanomagenesis, to Be Diagnostically Useful: Genomic Analysis of 88 Cases.
McFadden JR; Chaudhari AS; Stevanovic M; Tsongalis GJ; Hughes EG; Sriharan A
Am J Dermatopathol; 2023 May; 45(5):311-319. PubMed ID: 36939129
[TBL] [Abstract][Full Text] [Related]
27. Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients.
Lally SE; Milman T; Orloff M; Dalvin LA; Eberhart CG; Heaphy CM; Rodriguez FJ; Lin CC; Dockery PW; Shields JA; Shields CL
Ophthalmology; 2022 Jun; 129(6):679-693. PubMed ID: 35085662
[TBL] [Abstract][Full Text] [Related]
28. TERT and AURKA gene copy number gains enhance the detection of acral lentiginous melanomas by fluorescence in situ hybridization.
Diaz A; Puig-Butillé JA; Valera A; Muñoz C; Costa D; Garcia-Herrera A; Carrera C; Sole F; Malvehy J; Puig S; Alos L
J Mol Diagn; 2014 Mar; 16(2):198-206. PubMed ID: 24374110
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of conjunctival melanoma].
Salazar Méndez R; Baamonde Arbaiza B; de la Roz Martín P; Parra Rodríguez T
Arch Soc Esp Oftalmol; 2014 Feb; 89(2):82-4. PubMed ID: 24269405
[TBL] [Abstract][Full Text] [Related]
30. The correlation of the standard 5 probe FISH assay with melanocytic tumors of uncertain malignant potential.
Muhlbauer A; Momtahen S; Mihm MC; Wang J; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():30-36. PubMed ID: 28648937
[TBL] [Abstract][Full Text] [Related]
31. A genome-wide high-resolution array-CGH analysis of cutaneous melanoma and comparison of array-CGH to FISH in diagnostic evaluation.
Wang L; Rao M; Fang Y; Hameed M; Viale A; Busam K; Jhanwar SC
J Mol Diagn; 2013 Sep; 15(5):581-91. PubMed ID: 23800576
[TBL] [Abstract][Full Text] [Related]
32. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
[TBL] [Abstract][Full Text] [Related]
33. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization.
Hossain D; Qian J; Adupe J; Drewnowska K; Bostwick DG
Melanoma Res; 2011 Oct; 21(5):426-30. PubMed ID: 21900793
[TBL] [Abstract][Full Text] [Related]
35. Single Time Frame Overview of the Genetic Changes in Conjunctival Melanoma from Intraepithelial Disease to Invasive Melanoma: A Study of 4 Exenteration Specimens Illustrating the Potential Role of Cyclin D1.
Mudhar HS; Salvi SS; Pissaloux D; de La Fouchardiere A
Ocul Oncol Pathol; 2022 Feb; 8(1):52-63. PubMed ID: 35356600
[TBL] [Abstract][Full Text] [Related]
36. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
[TBL] [Abstract][Full Text] [Related]
37. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.
Gammon B; Beilfuss B; Guitart J; Gerami P
Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344
[TBL] [Abstract][Full Text] [Related]
38. Extensive conjunctival melanoma successfully treated with surgical resection and pre- and postoperative topical mitomycin C.
Mazzini C; Pieretti G; Vicini G; Nicolosi C; Virgili G; Giansanti F
Eur J Ophthalmol; 2021 Nov; 31(6):NP71-NP74. PubMed ID: 32674607
[TBL] [Abstract][Full Text] [Related]
39. Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma.
Dalton SR; Gerami P; Kolaitis NA; Charzan S; Werling R; LeBoit PE; Bastian BC
Am J Surg Pathol; 2010 Feb; 34(2):231-7. PubMed ID: 20087158
[TBL] [Abstract][Full Text] [Related]
40. Utility of fluorescence in situ hybridisation (FISH) in diagnosis and therapy of ocular melanocytic lesions.
Schauwvlieghe PP
Bull Soc Belge Ophtalmol; 2008; (309-310):55-6. PubMed ID: 19198555
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
